Nav: Home

Preventing blood clots with a new metric for heart function

January 30, 2017

The heart is a wonder of design - a pump that can function for 80 years, and billions of heartbeats, without breaking down. But when it does malfunction, the results can be dire.

In research reported in the International Journal of Cardiology this month, scientists from Johns Hopkins University and Ohio State presented a new method for predicting those most at risk for thrombus, or blood clots, in the heart.

The critical factor, the researchers found, is the degree to which the mitral jet - a stream of blood shot through the mitral valve - penetrates into the left ventricle of the heart. If the jet doesn't travel deep enough into the ventricle, it can prevent the heart from properly flushing blood from the chamber, potentially leading to clots, strokes and other dangerous consequences.

The findings were based on simulations performed using the Stampede supercomputer at the Texas Advanced Computing Center and validated using data from patients who both did and did not experience post-heart attack blood clots. The work was supported by grants from the National Science Foundation.

The metric that characterizes the jet penetration, which the researchers dub the E-wave propagation index (EPI), can be ascertained using standard diagnostic tools and clinical procedures that are currently used to assess patient risk of clot formation, but is much more accurate than current methods.

"The beauty of the index is that it doesn't require any additional measurements. It simply reformulates echocardiogram data into a new metric," said Rajat Mittal, a computational fluid dynamics expert and professor of engineering at Johns Hopkins University and one of the principal investigators on the research. "The clinician doesn't have to do any additional work."

Heart disease is the leading cause of death in the U.S. and by far the most expensive disease in terms of health care costs. Heart attacks cause some deaths; others result from blood clots, frequently the result of a heart weakened by disease or a traumatic injury.

Clots can occur whenever blood remains stagnant. Since the chambers of the heart are the largest reservoirs of blood in the body, they are the areas most at risk for generating clots.

Predicting when a patient is in danger of developing a blood clot is challenging for physicians. Patients recovering from a heart attack are frequently given anticoagulant drugs to prevent clotting, but these drugs have adverse side-effects.

Cardiologists currently use the ejection fraction - the percentage of blood flushed from the heart with each beat - as well as a few other factors, to predict which patients are at risk of a future clot.

For healthy individuals, 55 to 70 percent of the volume of the chamber is ejected out of the left ventricle with every heartbeat. For those with heart conditions, the ejection fraction can be reduced to as low as 15 percent and the risk of stagnation rises dramatically.

Though an important factor, the ejection fraction does not appear to be an accurate predictor of future clotting risk.

"Because we understood the fluid dynamics in the heart using our computational models, we reached the conclusion that the ejection fraction is not a very accurate measure of flow stasis in the left ventricle," Mittal said. "We showed very clearly that the ejection fraction is not able to differentiate a large fraction of these patient and stratify risk, whereas this E-wave propagation index can very accurately stratify who will get a clot and who will not," he said.

The results were the culmination of many years of investigation by Mittal and his collaborators into the fundamental relationship between the structure and function of the heart. To arrive at their hypothesis, the researchers captured detailed measurements from 13 patients and used those to construct high-fidelity, patient-specific models of the heart that take into account fluid flow, physical structures and bio-chemistry.

These models led, in turn, to new insights into the factors that correlate most closely to stagnation in the left ventricle, chief among them, mitral jet penetration.

Working in collaboration with clinicians, including lead author, Thura Harfi of Ohio State University, the team tested their hypothesis using data from 75 individual -- 25 healthy patients, 25 patients who experienced clots in their left ventricle, and 25 patients who had a compromised heart but who didn't have any clots.

Pending validation in a larger cohort of patients, the researchers found that based on the EPI measurement, one in every five patients with severe cardiomyopathy who are currently not being treated with anticoagulation, would be at risk of a left ventricular clot and would benefit from anticoagulation.

"Physicians and engineers don't interact as often as they should and that creates a knowledge gap that can be closed with this type of collaborative research," Harfi said. "Computational fluid dynamics is such an established way of studying phenomena in mechanical engineering, but has rarely been tried in humans. But now, with the development of high-resolution cardiac imaging techniques like cardiac computed tomography (CT) and the availability of supercomputing power, we can apply the power of computational fluid dynamics simulations to study blood flow in human beings. The information you get from a computer simulation you cannot get otherwise."

Mittal and his team required large computing resources to derive and test their hypothesis. Each simulation ran in parallel on 256 to 512 processors and took several 100,000 computing hours to complete.

"This work cannot be done by simulating a single case. Having a large enough sample size to base conclusions on was essential for this research," Mittal said. "We could never come close to being able to do what we needed to do it if weren't for Stampede."

Mittal foresees a time where doctors will perform patient-specific heart simulations routinely to determine the best course of treatment. However, hospitals would need systems hundreds of times faster than a current desktop computer to be able to figure out a solution locally in a reasonable timeframe.

In addition to establishing the new diagnostic tool for clinicians, Mittal's research helps advance new, efficient computational models that will be necessary to make patient-specific diagnostics feasible.

The team plans to continue to test their hypothesis, applying the EPI metric to a larger dataset. They hope in the future to run a clinical study with prospective, rather than retrospective, analysis.

With a better understanding of the mechanics of blood clots and ways to the predict them, the researchers have turned their attention to other sources of blood clots, including bio-prosthetic heart valves and atrial fibrillation (AFib) - a quivering or irregular heartbeat that affects 2.7 million Americans.

"These research results are an important first step to move our basic scientific understanding of the physics of how blood flows in the heart to real-time predictions and treatments for the well-being of patients," said Ronald Joslin, NSF Fluid Dynamics program director.

"The potential for impact in this area is very motivating," Mittal said, "not just for me but for my collaborators, students and post-docs as well."
-end-


University of Texas at Austin, Texas Advanced Computing Center

Related Blood Clots Articles:

Cellular senescence is associated with age-related blood clots
Cells that become senescent irrevocably stop dividing under stress, spewing out a mix of inflammatory proteins that lead to chronic inflammation as more and more of the cells accumulate over time.
New guidance on potentially fatal blood clots published today
The European Society of Cardiology (ESC) Guidelines on acute pulmonary embolism are published online today in European Heart Journal, and on the ESC website.
One in five haematological cancer patients suffer blood clots or bleeding
In the years following haematological cancer, one in five survivors suffer a blood clot or bleeding which requires hospital treatment.
Targeting inflammation to better understand dangerous blood clots
Forty percent of people who develop venous thromboembolism don't know what caused it.
Impeding white blood cells in antiphospholipid syndrome reduced blood clots
A new study examined APS at the cellular level and found that two drugs reduced development of blood clots in mice affected with the condition.
Research unlocks biomechanical mystery behind deadly blood clots
Researchers at the University of Sydney have used biomechanical engineering techniques to unlock the mystery surrounding the mechanical forces that influence blood clotting.
HRT tablets associated with increased risk of blood clots
Hormone replacement therapy (HRT) tablets are associated with a higher risk of rare but serious blood clots (known as venous thromboembolism or VTE), finds a large study in The BMJ today.
HRT tablets increase risk of blood clots in women
Women who use certain types of hormone replacement therapy (HRT) are at a higher risk of developing potentially life-threatening blood clots, new research has confirmed.
How and why blood clots shrink
In an article published in Nature Communications, researchers at the University of California, Riverside and the University of Pennsylvania School of Medicine used high-powered microscopy and rheometry -- the measurement of how materials become deformed in response to applied force -- to view the blood clotting process in real time and at the cellular level.
Can height increase risk for blood clots in veins?
Risk of blood clots in the veins was associated with height, with the lowest risk in participants who were five feet tall or shorter.
More Blood Clots News and Blood Clots Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.